Medicine
Vfend 200 mg tablet
Vfend 200 mg tablet is a prescription medicine containing Voriconazole for oral use, marketed by Roerig, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
If not used immediately, in-use storage times and conditions prior to use are…
Key facts
- Active ingredient (INN)
- Voriconazole
- Brand
- Vfend
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Roerig
- Manufacturer
- Roerig
- Origin register
- US FDA, United States
- Storage
- If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2°C to 8°C (36°F to 46°F). Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C to 8°C (36°F to 46°F). Do not refrigerate or freeze. VFEND Tablets should be stored at 15°C to 30°C (59°F to 86°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AC03 Voriconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 March 2003
- Identifiers
- RxCUI 349434, 349435, 351209 +5DailyMed set ID ce3ef5cf-3087-4d92-9d94-9eb8287228dbNDC 0049-3180Application NDA021266
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0049-3180-30 | Roerig | 28 March 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Voriconazole 200 mg tablet.
Other strengths and forms of Voriconazole
Clinical summary
Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with invasive aspergillosis, among other approved uses. MedsAcross supplies Voriconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VoriconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VFEND prescribing information (Roerig) · U.S. National Library of Medicine, DailyMed
- Vfend: European public assessment report (EPAR) · European Medicines Agency
- Voriconazole Accord: European public assessment report (EPAR) · European Medicines Agency
Need Vfend 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.